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EDITOR’S COMMENTS: 
One issue jumps out -- it seems highly implausible that the PLINK p values for individual 
regions are at the level of 5x10-5 after correction for multiple testing, given the sample sizes and 
the number of CNVs in each region (7:0, 5:0 as best as I could tell -- the data are not clearly 
presented and the Supplementary Tables referred to at this point in the text do not contain the 
relevant data).  As this is one of the remaining significant results in the manuscript, (the other 
main result is the overall excess of rare duplications, and is unreplicated) this point needs to be 
clarified.  If the results are really that significant, I would then worry about a systematic bias 
where there are more CNVs being called in general.  What does the QQ plot look like for all of 
the genomic regions analyzed by PLINK?  What is the inflation factor for this analysis?  What is 
the distribution of non-copy number 2 calls among the cases and among the controls (excluding 
trisomy 21 patients)?  Are there some cases that are outliers?  
 
RESPONSES: 
 
In the manuscript we presented separate analyses for genic and non-genic regions. The 
significant CNVs were in non-genic regions.  The tests presented were chi-squares and 
permutations were performed to obtain empirical p-values.  There were 457 non-genic regions, 
so the permutation corrected for 457 regions.  However, given that the most significant CNV was 
present in 7 cases and no controls while most other CNVs were less frequent, most CNVs were 
unable to produce such extreme p-values in the simulation and in effect the simulation was 
approximately equivalent to a Bonferroni correction for approximately 24 CNVs, since only 
those CNVs that are present 7 or more times can produce a p-value as small as the one obtained.  
 
We believe this test is valid, since it is based on the actual distribution of CNVs obtained, 
but also recognize that to be fair, the simulation should have included both all genic and non-
genic regions, so we have amended the paper accordingly. The three CNV regions remain 
genome-wide significant.  Therefore, the permutation empirical p-values reported (initially 
corrected for 457 non-genic regions) have been replaced with p-values corrected for 2439 total 
CNV regions (1982 genic and 457 non-genic regions).  One may argue that this test is still too 
liberal, since all CNVs with lower frequency cannot contribute to the correction, so we also now 
include the p-values from the more appropriate for low counts Fisher’s exact test, and include a 
Bonferroni correction for 2439 total CNV regions (1982 genic and 457 non-genic regions). In 
this case, two of the three CNV regions remain genome-wide significant.  However, this 
approach may be too conservative.   
 
The following table lists the initially reported results of the top three rare CNV regions, 
and results from the permutation test and Fisher’s exact test performed on and corrected for the 
2439 CNV regions (1982 genic regions and 457 non-genic regions). We now include a new table 
in the main text showing the results of the top three rare CNV regions from both the permutation 
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test and Fisher’s exact test (Table 3 – pasted below), and the QQ plots of these tests in the 
supplementary materials (Supplementary Figures 9a and b – pasted below). 
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Table: The initially reported results of the top three rare CNV regions, and results from the permutation test and Fisher’s exact test 
performed on and corrected for the 2439 CNV regions (1982 genic regions and 457 non-genic regions) 
Chr. 
Starting 
position 
(in hg18) 
Ending 
position 
(in hg18) 
Number 
of cases 
Number 
of 
controls 
Permutation test  
(initially reported) 
 Permutation test  
(now included) 
 Fisher’s exact test 
Empirical 
p-values  
Empirical p-values 
corrected for all 
non-genic regions 
(N=457) 
 
Empirical 
p-values  
Empirical p-values 
corrected for all genic 
and non-genic regions 
(N=2439) 
 p-values  
p-values 
after 
Bonferroni 
correction 
7 38285115 38330273 7 0 1.00 x10
-06
 6.59x10
-5
  2.00 x10
-06
 0.000147  3.20x10
-06
 0.00779436 
14 21937715 22009307 6 0 0.000139 7.16x10
-4
  0.000134 0.001372  1.98 x10
-05
 0.048239486 
1 40794563 40804646 7 3 0.000228 0.011  0.000240 0.022894  0.0002435 0.594073571 
Genic and non-genic regions are defined as those that harbour at least one CNV in cases or controls.  These three regions do not harbor any 
genes, i.e. non-genic regions. Permutation tests (1,000,000 iterations) were initially performed on 457 rare non-genic regions and corrected 
for these regions. According to PLINK, the empirical p-values corrected for all the tests were calculated by comparing each observed test 
statistic against the maximum of all permuted statistics (i.e. over all regions) for each single replicate. 
 
Now we replaced the reported values with the results from permutation test performed on 2439 rare CNV regions (1982 genic regions and 
457 non-genic regions) by using PLINK, and corrected for all these 2439 regions. We also performed the Fisher’s exact test on these regions, 
and included a Bonferroni correction for 2439 total CNV regions. 
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We have also modified the text in the supplementary materials and methods under the 
section “Rare copy number variation regions (CNVRs) analysis - genic and non-genic regions” 
as below: 
“Rare CNVRs were divided into two categories: genic CNVRs and non-genic CNVRs.  Genic 
CNVRs were genic regions (based on RefSeq genes extended by 5kb upstream and downstream) 
in which a CNV resides.  Non-genic CNVRs are defined by regions that result from the union of 
overlapping CNVs that do not intersect any genic CNVRs (Supplementary Figure 5).  Simple 
permutation-based (1-sided) test of association was performed for each all genic and non-genic 
CNVRs together (with 1,000,000 iterations) by using PLINK to test if there are significantly 
more cases that have CNV in the defined region. The empirical p-values corrected for all the 
tests were also calculated by comparing each observed test statistic against the maximum of all 
permuted statistics (i.e. over all regions) for each single replicate. 
 
One may argue that this test is still too liberal, since all CNVs with lower frequency cannot 
contribute to the correction, so we also performed the more appropriate for low counts Fisher’s 
exact test by using R, and included a Bonferroni correction for 2439 total rare CNV regions 
(1982 genic and 457 non-genic regions).” 
 
Changes were also made accordingly in the Results section in the main text under the 
heading “Rare CNVRs that are statistically associated to ARMs”: 
“Following the global rare CNVs enrichment observed in the patients, rare CNV regions (CNVR; genic: 
N=457 and non-genic: N=1982) were defined (see Supplementary Figure 5) and individually evaluated 
for their associations with ARMs by using permutation tests.  The number of CNVs within each defined 
CNVR was compared between patients and controls.  We also performed the more appropriate for 
low counts Fisher’s exact test, and included a Bonferroni correction for 2439 total rare CNV 
regions. 
Using permutation tests, we identified 3 non-genic CNV regions that were statistically associated 
with ARMs on 7p14.1 (corrected empirical p-value = 0.000147; p-value from Fisher’s exact test 
after Bonferroni correction = 0.00779), 14q11.2 (corrected empirical p-value = 0.00137; p-
value from Fisher’s exact test after Bonferroni correction = 0.0482), and 1p34.2 (corrected 
empirical p-value = 0.0229; p-value from Fisher’s exact test after Bonferroni correction = 0.594) 
(Supplementary Figures 8a, b and c) (Table 3).  All were hemizygous deletions. 
Deletions on 7p14.1 (a 45kb region) were observed in 7 ARM-patients (6 isolated; 1 with bifid scrotum) 
but in none of the controls.  This region (5.3kb upstream of TARP (TCR gamma alternate reading frame 
protein) overlaps a 411bp CpG island and a transcription factor binding site (Supplementary Figure 8a).  
Deletions on 14q11.2 (a 73kb region) were observed in 5 ARMs cases (3 isolated; 1 with bifid scrotum, 1 
with Down syndrome) but not in our controls (Supplementary Figure 8b).  The 1p34.2 ARMs-associated 
deletion was detected in 7 ARM-patients (6 isolated; 1 with heart and kidney anomalies) and in 3 control 
individuals (Supplementary Figure 8c).” 
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Regarding the total number of rare CNVs in cases and controls, we now include 3 supplementary 
figures (Supplementary Figures 10 a, b and c – pasted below) showing the distributions of them. 
Coinciding with the global burden test performed on rare CNVs (as shown in Table 1), 
there are generally more rare CNVs in cases than in controls, as the whole distribution of 
cases is on the right of that of controls (Supplementary Figures 10a). There are no outlier 
cases. In one of our QC procedures, samples with genome-wide LRR standard deviation greater 
than 3.5 or with more than 500 CNVs called were already excluded from the analysis (patients=5; 
controls=17). Those individuals with CNVs in the three top non-genic regions were also 
examined for their total number of rare CNVs. A new supplementary table (Supplementary Table 
14 – pasted below) is now included.  
 
The median of the observed chi-square statistics for these genic and non-genic regions is 0 while 
the expected median should be around 0.456 (i.e. inflation factor is equal to 0).  The test statistics 
are deflated as many of the CNVs are present only once (N=1238) (no chi-square can be 
computed).  Therefore, correcting for 2439 total rare CNV regions (Bonferroni correction) may 
be over conservative, yet the association is still statistically significant for the 7p14.1 and 
14q11.2 regions. 
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Table 3: Results of the top three rare CNV regions from the permutation test and Fisher’s exact test.  
Chr. 
Starting 
position 
(in hg18) 
Ending 
position 
(in hg18) 
Number 
of cases 
Number of 
controls 
Permutation test  Fisher’s exact test 
Empirical p-values  
Empirical p-
values corrected 
for all tests 
 p-values  
p-values after 
Bonferroni 
correction 
7 38285115 38330273 7 0 2.00 x10
-06
 0.000147  3.20x10
-06
 0.00779436 
14 21937715 22009307 6 0 0.000134 0.001372  1.98 x10
-05
 0.048239486 
1 40794563 40804646 7 3 0.000240 0.022894  0.000243573 0.594073571 
Genic and non-genic regions are defined as those that harbour at least one CNV in cases or controls.  These three regions do not harbor 
any genes, i.e. non-genic regions.  Permutation tests (1,000,000 iterations) were performed on 2439 rare CNV regions (1982 genic 
regions and 457 non-genic regions) by using PLINK.  According to PLINK, the empirical p-values corrected for all the tests were 
calculated by comparing each observed test statistic against the maximum of all permuted statistics (i.e. over all regions) for each single 
replicate.  We also performed the Fisher’s exact test on these regions, and included a Bonferroni correction for 2439 total CNV regions. 
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Supplementary Figure 9: QQ-plot of the association tests performed on the 2439 rare CNV 
regions (1982 genic regions and 457 non-genic regions) 
(a) QQ-plot of the permutation tests (1,000,000 iterations) results that were generated based 
on the 2439 rare CNV regions by using PLINK 
 
(b) QQ-plot of the Fisher’s exact test results that were generated based on the 2439 rare CNV 
regions  
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Supplementary Figure 10: Distribution of the total number of rare CNVs in cases and 
controls  
Coinciding with the global burden test performed on rare CNVs (as shown in Table 1), there are 
generally more rare CNVs in cases than in controls, as the whole distribution of cases is on the 
right of that of controls (a). The distribution of the total number of rare CNVs in cases is 
displayed in red, while the distribution in controls is displayed in blue. No outlier case is 
observed. Histograms are also shown alongside with the one after Kernel density smoothing.  
NSEG: total number of rare CNVs 
(a) Kernel density smoothing of the histogram, which allows better visual comparison of the 
two distributions.  
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(b) Histogram of the total number of rare CNVs in cases  
 
 
(c) Histogram of the total number of rare CNVs in controls  
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Supplementary Table 14: Total number of rare CNVs in those individuals who have CNVs in 
the three top non-genic regions 
 
Chr. 
Starting position 
(in hg18) 
Ending position 
(in hg18) 
Sample ID 
Affection 
status 
Total number of rare 
CNVs 
7 38285115 38330273 MG-IA218C Case 7 
   
MG-IA105C Case 8 
   
MG-IA98C Case 8 
   
MG-IA179C Case 8 
   
MG-IA220C Case 8 
   
MG-IA95C Case 7 
   
MG-IA381C Case 7 
14 21937715 22009307 MG-IA179C Case 8 
   
MG-IA126C Case 5 
   
MG-IA105C Case 8 
   
MG-IA220C Case 8 
   
MG-IA98C Case 8 
   
MG-IA105C Case 8 
1 40794563 40804646 MG-IA158C Case 8 
   
MG-IA161C Case 5 
   
MG-IA338C Case 8 
   
MG-IA344C Case 3 
   
MG-IA365C Case 4 
   
MG-IA327C Case 3 
   
MG-IA106C Case 3 
   
AK2858 Control 1 
   
AK6029 Control 4 
   
HTP529 Control 6 
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ABSTRACT 
Anorectal malformations (ARMs, congenital obstruction of the anal opening) are among the 
most common birth defects requiring surgical treatment (2-5/10,000 live-births) and carry 
significant chronic morbidity.  ARMs present either as isolated or as part of the phenotypic 
spectrum of some chromosomal abnormalities or monogenic syndromes.  The etiology is 
unknown.  To assess the genetic contribution to ARMs, we investigated single nucleotide 
polymorphisms (SNPs) and copy number variations (CNVs) at genome-wide scale.  A total of 
363 Han Chinese sporadic ARM-patients and 4,006 Han Chinese controls were included.  
Overall, we detected a 1.3-fold significant excess of rare-CNVs in patients.  Stratification of 
patients by presence/absence of other congenital anomalies showed that while syndromic-ARM 
patients carried significantly longer rare duplications than controls (p=0.049), non-syndromic 
patients were enriched with both rare deletions and duplications when compared to controls 
(p=0.00031).  Twelve chromosomal aberrations and 114 rare-CNVs were observed in patients 
but not in 868 controls nor 11,943 healthy individuals from the Database of Genomic Variants 
(DGV).  Importantly, these aberrations were observed in isolated-ARM patients.  Gene-based 
analysis revealed 79 genes interfered by CNVs in patients only.  In particular, we identified a de 
novo DKK4 duplication.  DKK4 is a member of the WNT signaling pathway which is involved in 
the development of the anorectal region.  In mice, Wnt disruption results in ARMs.  Our data 
suggest a role for rare-CNVs not only in syndromic but also in isolated-ARM patients and 
provide a list of plausible candidate genes for the disorder. 
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INTRODUCTION 
Anorectal malformations (ARMs, congenital obstruction of the anal opening) are among the 
most common birth defects requiring surgical treatment (2-5/10,000 live-births (1)) and carry a 
significant chronic morbidity.  The condition is attributed to a defect in the proliferation of the 
embryonic rudiments that will form the distal end of the gut,, and it is probably due to disorders 
in the expression of pattern determining genes.  The spectrum of ARMs ranges from anal 
stenosis to imperforated anus with/without anal fistula to persistent cloaca, in which the intestinal 
and genitourinary tracts remain a common channel.  ARMs might appear as part of the 
phenotypic spectrum of many chromosomal abnormalities (2-4) or monogenic syndromes (5, 6).   
The etiology of ARMs remains unknown.  While environmental factors are not to be 
dismissed, several lines of evidence indicate that there is a genetic component (7).  Indeed, even 
though ARMs appear mostly sporadically (no affected relatives), they also segregate within 
families with patterns of inheritance ranging from autosomal-dominant, X-linked, to autosomal-
recessive (8-10).  Moreover, higher risk of anal atresia/stenosis has been associated with 
consanguinity (11).  
The approach currently being taken towards the discovery of genes involved in isolated-
ARMs in humans is that of the analysis of candidate genes selected according to the data 
provided by (i) their role in syndromes that include ARMs as part of their spectrum; (ii) mutant 
mice/rat studies (12, 13) as in most cases, mutations in the human orthologs give rise to similar 
or related phenotypes.  However, while mice mutant for Shh, Gli2, or Gli3 display different 
congenital defects that include ARMs as a common feature, point mutations in the human 
orthologs (SHH, GLI3) are associated with syndromes or genetically heterogeneous disorders in 
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which the ARMs phenotype is not always the norm.  Failure to identify human genes underlying 
ARMs so far may be attributed to the reason that there is no single major gene, suggesting 
genetic and phenotypic heterogeneity.   
To explore the genetic contribution to the pathogenesis of this condition, we investigated 
at genome-wide scale, single nucleotide polymorphisms (SNPs) and copy number variations 
(CNVs) on Han Chinese ARM patients.  Patients were also stratified into those presenting ARMs 
as an isolated feature and those presenting ARMs together with associated anomalies and 
analyzed accordingly.   
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RESULTS 
Common variants do not contribute to the isolated-ARMs phenotype  
Common single nucleotide polymorphisms (SNPs)  
After stringent quality control (QC) on genome-wide association study (GWAS) genotypes, 489, 
243 SNPs (average call rate 99.85%) that were successfully genotyped in 175 ARMs cases and 
2,971 controls were tested for association to ARMs under additive, dominant and recessive 
models.  After correcting for the first 12 principal components (i.e. correcting for population 
stratification), 48 SNPs reached association p-values <10
-4
 under the additive model 
(Supplementary Table 3).  No SNP reached genome-wide significance (p<10
-8
).  QQ-plot and 
Manhattan plot of the association test results were shown in supplementary Figure 2 and 3 
respectively. The genomic inflation factor after principal components analysis (PCA) correction 
did not deviate from 1 (λ=1.0093) indicating that chances of spurious associations due to the 
population substructure were minimal.   
As PCA had revealed that two subpopulations of Han Chinese (Northern and Southern) 
existed in our dataset (see Supplementary Figure 1), we then performed association tests 
separately to assess if susceptibility loci differed between the two subpopulations.  When the 
Northern Chinese patients (N=103) were tested for ARMs association against Northern Chinese 
controls (N=1411), we identified 44 SNPs with association p-values <10
-4
 under the additive 
model.  As for the Southern Chinese (patients: N=72; controls: N=1560) we identified 42 SNPs 
with p-values<10
-4
.  Similar results were obtained when patients were stratified according to the 
presence/absence of additional anomalies or syndromes (data not shown).   
We then proceed to replicate the signals detected in the discovery phase.  After QC, 110 
SNPs were successfully genotyped on 167 patients affected with isolated ARM (Northern: N=81, 
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Southern: N=86) and 174 normal controls (Northern: N=88, Southern: N=86).  Meta-analysis of 
all Han Chinese revealed that none of the combined p-values for the SNP tested reached 
genome-wide significant level.   
 
Copy Number Polymorphisms (CNPs) 
Global burden of CNPs were examined in all cases and controls in terms of length, frequency 
and number of genic regions overlapped.  None of the global burden test results was statistically 
significant (see Supplementary Table 6), thus suggesting that there is no enrichment of common 
CNVs in cases compared with controls.  Similar results were obtained when the analysis was 
performed on stratified patients (isolated or syndromic patients with ARMs).  
Lack of ARMs association with common susceptibility loci may also imply that the 
disorder results from variants whose frequency in the population is lower than 1% (rare variants).  
Using the same data set, we proceeded to study the contribution of rare CNVs to the ARMs 
phenotype as described in the following sections.  
 
Rare CNVs contribute to ARMs 
Global burden analysis: ARM patients are enriched with rare CNVs  
Rare CNVs are known to play a more significant role in disease susceptibility than CNPs 
(common CNVs) (15, 16).  Thus, global burden of rare CNVs (defined as CNVs that are 
observed in less than 1% samples of the dataset) was compared between cases and controls using 
permutation tests (1,000,000 iterations).  Patients were enriched with rare deletions and rare 
duplications by 1.3 fold each. Rare CNVs were classified into two groups in terms of size 
(length<100kb or length>100kb) and their distributions in patients and controls are 
Page 18 of 52Human Molecular Genetics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
8 
 
tabulated in Table 1.  Globally, more duplications were identified in ARM patients (CNV with 
length < 100kb: empirical p-value = 0.007344; CNV with length >100kb: empirical p-value = 
0.002307) when compared to controls.   
Significant enrichment of rare duplications (CNV with length < 100kb: empirical p-value 
= 0.0187; CNV with length >100kb: empirical p-value = 0.0064) and deletions (CNV with 
length < 100kb: empirical p-value = 0.0102; CNV with length >100kb: empirical p-value = 
0.0181) were observed in non-syndromic patients (isolated ARMs, N=126), while interestingly, 
syndromic patients (N=44, among which 15 have Down syndrome) were only modestly enriched 
with long duplications (length > 100kb, empirical p-value = 0.0490). The results were tabulated 
in supplementary Tables 7a and b. Although the association tests are significant, it would be 
important to replicate the excess in deletions and duplications in an independent group of 
patients and controls of all ancestries available.    
 
Chromosomal aberrations  
Within the set of long CNVs, we examined closely those CNV longer than 1Mb which are 
referred to as chromosomal aberrations.  Global burden analysis revealed that, overall, ARM-
patients have 3 fold more chromosomal aberrations (defined as longer than 1Mb) than controls 
(p=0.0368 for deletions and p=0.00614 for duplications) even after excluding patients with 
Down syndrome (around 9% of our ARM-patients) (see Supplementary Tables 8a and b).  The 
chromosomal aberrations in ARM-patients also spanned more genic regions than those in 
controls.  This applied to either deletions (empirical p-value=0.00038) or duplications (empirical 
p-value=0.000226).   
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 Importantly, we identified 12 chromosomal aberrations (besides trisomy 21) that were 
unique to ARM patients as they were not identified in controls or in the normal individuals of the 
Database of Genomic Variants (DGV) (Table 2).  Seven chromosomal aberrations encompassed 
genes that were not disrupted in controls.  The chromosomal aberrations observed were checked 
against the Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl 
Resources (DECIPHER) which is a database of submicroscopic chromosomal imbalances and 
clinical information for 6,169 patients with developmental disorders.  There were five 
aberrations that had also been found in DECIPHER patients with similar or ARM-related 
symptoms.   
 Interestingly, a 2.5Mb heterozygous deletion on chromosome 22q11.21 was identified in 
one affected female (MG-IA162C, isolated-ARM).  Deletions involving 22q11.21 had been 
reported in a patient with VACTERL syndrome, which includes ARMs as part of the spectrum 
(17), and in 5 other syndromic ARM patients (18-20).  Chromosomal aberrations on 
chromosome 22q11.21 were also reported in five DECIPHER patients with hindgut problems 
(Table 2), including 1 patient with isolated-ARM and 1 syndromic patient with sacrum and 
kidney anomalies.  Thus, it would appear that chromosomal aberrations involving this region are 
not only involved in syndromes with ARMs as part of the phenotypic spectrum but also in the 
isolated ARMs phenotype (21).  CNVs that overlap known critical regions are likely to be 
pathogenic in nature.  Importantly, these chromosomal aberrations were identified in patients 
with the ARM-isolated phenotype. 
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Rare CNVRs that are statistically associated to ARMs  
Following the global rare CNVs enrichment observed in the patients, rare CNV regions (CNVR; 
genic: N=457 and non-genic: N=1982) were defined (see Supplementary Figure 5) and 
individually evaluated for their associations with ARMs by using permutation tests.  The number 
of CNVs within each defined CNVR was compared between patients and controls.  We also 
performed the more appropriate for low counts Fisher’s exact test, and included a Bonferroni 
correction for 2439 total rare CNV regions. 
Using permutation tests, we identified 3 non-genic CNV regions that were statistically 
associated with ARMs on 7p14.1 (corrected empirical p-value = 0.000147; p-value from Fisher’s 
exact test after Bonferroni correction = 0.00779), 14q11.2 (corrected empirical p-value = 
0.00137; p-value from Fisher’s exact test after Bonferroni correction = 0.0482), and 1p34.2 
(corrected empirical p-value = 0.0229; p-value from Fisher’s exact test after Bonferroni 
correction = 0.594) (Supplementary Figures 8a, b and c) (Table 3).  All were hemizygous 
deletions. 
Deletions on 7p14.1 (a 45kb region) were observed in 7 ARM-patients (6 isolated; 1 with 
bifid scrotum) but in none of the controls.  This region (5.3kb upstream of TARP (TCR gamma 
alternate reading frame protein) overlaps a 411bp CpG island and a transcription factor binding 
site (Supplementary Figure 8a).  Deletions on 14q11.2 (a 73kb region) were observed in 5 ARMs 
cases (3 isolated; 1 with bifid scrotum, 1 with Down syndrome) but not in our controls 
(Supplementary Figure 8b).  The 1p34.2 ARMs-associated deletion was detected in 7 ARM-
patients (6 isolated; 1 with heart and kidney anomalies) and in 3 control individuals 
(Supplementary Figure 8c).   
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 These 3 non-genic regions overlapped with CNVs listed in the Database of Genomic 
Variants (DGV).  Yet, given their associations with the ARMs phenotype it is tempting to 
speculate that they affect regulatory sites and that may contribute to disease in conjunction with 
additional altered loci.   
 
Rare CNVs unique to ARM patients  
As rare-CNVs are more likely to be pathogenic if they involve gene-rich regions and are only 
found in affected individuals, we proceeded with the identification of rare-CNVs that were 
exclusive to ARM patients (Supplementary Figure 6).  This yielded 433 CNVs of which 342 
were observed only once (non-recurrent) and 91 CNVs (distributed in a total of 35 CNVR–
regions-) were observed in more than one patients (recurrent; Supplementary Table 10).  We 
then filtered these CNVs against the DGV and this resulted in 114 CNVs that not only were 
exclusive to ARM patients, but also were absent in control individuals in the DGV.  While 9 
were recurrent (distributed in 4 CNVR-regions-), 105 were non-recurrent (Supplementary Table 
11).  These CNVs were subsequently classified according to their genic content (genic and non-
genic CNVs).   
 
Gene-based analysis: genes of the WNT and SHH signaling pathways are disrupted in ARM 
patients 
As the pathogenicity of a genic CNV may be linked to not only the number of genes included but 
also to the biologically plausibility of the gene in relation to the phenotype under study, genes 
intersected by the CNVs were carefully scrutinized and prioritized.  We then performed a gene-
based analysis in which all CNVs were included.  We identified 496 genes that were not 
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disrupted in controls (472 unique -disrupted in one patient-; 24 recurrent, Supplementary Table 
12).  After filtering against the CNVs of 11,943 healthy controls from the DGV, 79 genes 
(Supplementary Table 13) were found to be uniquely interfered by CNVs in our patients 
(Supplementary Figure 7).   
 Given the relevance of the WNT and SHH interrelated signaling pathways in embryonic 
development, together with the human ARM-reminiscent phenotypes displayed by animal 
models for those pathways (22, 23), we explored those CNV events that overlap with gene 
members of the WNT/SHH signaling pathways.  We identified 2 patients (MG-IA349C-isolated-; 
MG-IA78C with Down syndrome) with a 34.4kb heterozygous deletion spanning exon 5 to exon 
8 of INTU (4q28.1; Figure 1a), and one patient (MG-IA147C: isolated imperforate anus and 
diagnosed with autism at the age of 6) with a duplication (3 copies) of the whole DKK4 gene 
(8p11.21; Figure 1b).  These computationally predicted CNVs were validated using Taqman® 
copy number assays (Figures 2a, b).  Importantly, the duplication of DKK4 was de novo (Figure 
2c).  The inherited or de novo nature of the INTU deletion could not be established as parental 
DNA was not available.   
 INTU (inturned planar cell polarity effector homolog) encodes a structural protein that 
controls ciliogenesis and the organization of the cytoskeleton (governing the apical actin 
assembly and controlling the orientation of ciliary microtubules) and its disruption is associated 
with the failure in planar cell polarity (PCP) and hedgehog signaling pathways (24, 25).  Many 
hedgehog pathway components, including the Gli family of transcription factors, localize to cilia 
and proper Intu expression is required for their ciliary translocation to the nucleus (26-29).  
Mutations in Intu cause loss of Shh signaling (Gli1 protein) in the mouse posterior spinal cord, 
and mice die at E9.5(26).  Importantly, defects in SHH (i.e. mutation in Gli2 and/or Gli3) or 
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planar cell polarity (PCP) signaling lead to the ARM phenotype in mice (22, 23). The effect is 
dosage-dependent, i.e. more severe phenotypes are observed when two copies of the mutated 
genes are defective (22). Yet no coding region mutations in these genes have been identified in 
humans affected with isolated ARMs.  GLI3 coding sequence mutations are associated with 
Pallister-Hall syndrome (OMIM # #146510) which includes imperforate anus its phenotypic 
spectrum.   
 
Excess of DKK4 leads to ARMs  
DKK4 encodes a secreted protein member of dickkopf (DKK) family of WNT regulators.  DKKs, 
together with WNT secreted proteins play an important role in antero-posterior axial patterning, 
limb development, somitogenesis and eye formation(30).  During development, DKK4 competes 
with WNT ligands for the co-receptors, thus antagonizing WNT signaling pathway.  In mice, 
defects in Wnt signaling pathway lead to anorectal malformations (12, 13, 30, 31).   
From all of the above, it would appear that deregulation of the WNT pathway by 
overexpression of DKK4 may further impair WNT signaling and lead to ARMs.  We then tested 
this hypothesis in a mouse anorectum organotypic culture. The urogenital sinus and the hindgut 
are connected at the cloaca at E12 in mouse embryo (Figure 3a). By E13.5, the cloaca is being 
separated by a sheet of mesenchyme called urorectal septum, which has elongated and descended 
towards the cloaca membrane (Figure 3b), and at the same time, the genital tubercle has grown 
distally due to the proliferation of the rostral mesoderm of the genital tubercle. This process 
compartmentalizes the cloaca into two cavities from which the anal opening and urethra opening 
will originate respectively.  In control culture, the genital tubercle has grown distally after 36 
hours. The urorectal septum has already elongated and reached the cloaca membrane (Figure 3c).  
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In contrast, treatment with Dkk4 protein (Figure 3d) perturbed the growth of the urorectal 
septum and resulted in the lack of cloaca compartmentalisation. The hollow space resembled the 
phenotype of persistent cloaca as shown in the mid-sagittal section depicted in Figure 3b.  
However, the distal growth of the genital tubercle appeared unaffected by the addition of Dkk4 
protein. This experiment proves that excess of DKK4 may lead to anorectal malformations.  
Therefore, it would appear that DKK4 is a candidate gene for ARMs.  
 However as Intu is a cytoplasmatic protein, we could not test the effect of deletion 
directly by employing the same experiment design. Mutations in Intu had been reported before 
that they cause loss of SHH signaling (Gli1 protein) in the mouse posterior spinal cord, and mice 
die at E9.5(26).  Therefore, remaining support for selecting INTU as a possible candidate 
gene is the fact that it is within a rare CNV and that it is involved in SHH signaling.  
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DISCUSSION  
CNVs are abundant and can be functionally influential.  Their importance in human 
diseases has become increasingly apparent over the past five years.  With the advancement in 
detection resolution and genome coverage of genotyping arrays, detection of copy number 
variations at genome-wide scale is possible.  Based on the intensity of SNP and CNV probes in 
the array, CNVs can be predicted and analyzed for their association to the disease.  Several large-
scale studies have reported that CNVs, especially rare CNVs, may account for a significant 
proportion of human phenotypic variation, including disease susceptibility (32, 33).  Data from 
the latest CNV studies indicate that disease status is more likely to be caused by an accumulation 
of rare CNVs rather than by differences in CNP loads (33).  We now appreciate that at least 15% 
of human neurodevelopmental diseases are due to rare and large copy number changes which 
lead to local dosage imbalance for dozens of genes.  Large CNVs, both inherited and de novo, 
have been implicated in the etiology of autism, schizophrenia, kidney dysfunction, and 
congenital heart disease (34).  Studies of the general population suggest that collectively, rare 
CNVs are quite common and are under strong purifying selection.  This implies that a significant 
fraction of the human population carries an unbalanced genome and such individuals, may be 
sensitized by the effect of another variant interacting with these CNVs in a digenic manner.   
One of the major challenges in CNV discovery is to discriminate between benign and 
pathological variants.  The rarer or longer the CNV, the more likely it is to be pathogenic.  CNV 
is also more likely to be pathogenic when the genetic event is de novo, when CNVs are found 
only in patients and when the genes encompassed or disrupted by the CNV belong to a pathway 
known to contain genes associated with a similar phenotype under study (35, 36). Indeed, many 
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of the CNVs identified in this study meet some of the above criteria.  Besides the 114 rare CNVs 
exclusive to ARM patients, rare CNVs were overall in excess in the patients.  Moreover, some 
CNVs not only intersected with gene members of pathways (i.e. SHH and WNT) that are 
involved in the development of the anorectal region, but also contained genes associated with 
similar or related phenotypes in mice and humans (12-14, 22, 31, 37).  Importantly, we could 
prove that the DKK4 duplication was de novo.  Interestingly, while mice mutant for SHH gene 
members (Shh, Gli2, or Gli3) displayed congenital defects that include ARMs as a common 
feature, point mutations in the human orthologs (SHH, GLI3) are associated with syndromes or 
genetically heterogeneous disorders in which the ARM phenotype is not always the norm.   
 As any other developmental disorders, rare chromosome aberrations (CNV longer than 
1Mb) have been reported in 4.5–11% of the patients, mostly with syndromic ARMs (21).  Indeed, 
ARMs can be part of the phenotypic spectrum of many chromosomal anomalies such as trisomy 
13, 18, 21 or 22 to mention a few (21, 38).  Here, we identified 12 chromosomal aberrations 
(besides trisomy 21) that were unique to isolated-ARM patients, indicating a role for those 
aberrations in isolated-ARMs.   
 Developmental disorders are notoriously associated with a myriad of rare chromosomal 
aberrations and CNVs, and their rarity makes clinical interpretation problematic and genotype-
phenotype correlations uncertain.  A genomic rearrangement shared by patients with phenotypic 
features in common surely implies greater certainty in the pathogenic nature of the CNV.  
Comparison of the chromosomal aberrations unique to ARM patients with those reported in 
patients of DECIPHER (Table 2) or in The European Cytogeneticists Association Register of 
Unbalanced Chromosome Aberrations (ECARUCA) has revealed the presence of the 22q11.2 
deletion in the later of 6 cases with syndromic ARMs (21).  A similar deletion was detected in 
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one of our patients with isolated-ARMs.  Likewise, our patients shared rearrangements with 
DECIPHER patients with related phenotypes. 
Surely, rare CNVs implicate several novel disease candidates genes since there is a 
multitude of ways in which gene function can be altered by these structural variations (alter gene 
dosage, disrupt coding sequences, or affect gene regulation and consequently may lead to 
disease).  Indeed, our initial analyses showed an excess of rare CNVs in ARM-patients when 
compared to controls, with 79 genes disrupted by CNVs uniquely in patients, providing a wealth 
of putative disease candidate genes, in particular DKK4 and INTU.  Common genetic variants 
(SNPs and CNPs) have been found to have little contribution to the condition as ARMs, being 
phenotypically heterogeneous, are likely to result from rare mutations in a variety of genes.  As 
in many other congenital diseases, several genes acting in different tissues and at different 
developmental stages may be involved in ARMs.  Mutations in any of these genes could lead to 
the phenotype.  Because each gene and its product are subject to complex regulation at every 
stage, the reach of a mutational event will depend on the gene implicated.  Thus, the complexity 
of these molecular events would explain both the genetic heterogeneity and phenotypic 
variability of the condition.  Our data suggest that the condition is likely caused by rare variants 
(CNV or single point mutation) in any of the genes implicated in the developmental processes.  
This would be in line with the lack of association signals for common genetic variants and the 
manifestation of the disease.  Thus, rare DNA variations in any of the developmental genes 
implicated could not only lead to the phenotype but also explain its variability on the grounds 
mentioned above.   
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MATERIALS AND METHODS 
Subjects and ethics statement 
The overall study was approved by the institutional review board of The University of Hong 
Kong together with the Hospital Authority (IRB: UW 07-321).  Blood samples were drawn from 
all participants after obtaining informed consent (parental consent in newborns and children 
below age 7).   
 
ARM patients 
A total of 363 Chinese sporadic ARM patients (isolated or with additional associated anomalies) 
had prospectively been collected throughout Hong Kong and Mainland China.  All patients 
included in this study went through renal ultrasound, lumbosacral radiography and ECHO 
cardiography.  Patients were initially grouped into discovery phase by genome-wide scan (185 
patients) and replication series (178 non-syndromic patients).  The overall male-to-female ratio 
was approximately 1.4:1.  Phenotypic characteristics of the patients are summarized in 
Supplementary Table 1.  Patients were defined as syndromic if associated anomalies were 
observed in addition to ARMs (see Supplementary Table 1b).  In the discovery phase, we 
included 46 syndromic ARM patients, among whom 15 had Down syndrome. 
 
Controls 
As controls, we used the DNA sample from a total of 3,249 Chinese individuals (discovery 
phase: N=3,072, replication phase: N=177) whom also recruited throughout Hong Kong and 
Mainland China. For the discovery phase, we included 3,072 individuals who were either 
phenotypically normal (N=1,421) or affected with conditions other than ARMs (N=1,651).  
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These 1,651 individuals (“shared” controls) had been included in other GWAS conducted in our 
institution (i.e. patients affected with schizophrenia, hypertension(39), epilepsy(40) or systemic 
lupus erythematosus(41)).  Details on the characteristics of the shared controls can be found in 
Supplementary Table 2.  Individuals affected with other conditions were used as controls 
because: i) disease-specific effect in the controls can be diluted if it consists of balanced disease 
samples; ii) sharing samples from different projects can detect differential errors due to different 
DNA preparation and genotyping; iii) cost is reduced for collecting phenotype and genotype data 
from additional control samples; iv) power increases with the number of controls used.  For the 
SNP replication phase, 177 phenotypically normal individuals were recruited as controls.  For 
the CNV analysis, we included 868 individuals who are phenotypically normal from other 
studies (111 controls from hypertension study and 757 individuals from osteoporosis study (42)).   
 
Discovery phase  
Whole-genome scan 
The whole-genome scan was performed at deCODE Genetics (Reykjavik, Iceland) using 
Illumina Human 610-Quad BeadChips which assay 599,011 SNPs across the genome and  
21,890 intensity-only CNV probes.  SNP calls were provided by deCODE.  SNP quality control 
and association tests together with the results are detailed in the supplementary material and 
methods. 
 
CNVs: predictions  
CNV segments were predicted by two programs, PennCNV (43) and QuantiSNP (44), the two 
most efficient and publicly available CNV calling algorithms for Illumina data (45).  Both 
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programs implement hidden Markov models (HMM) while PennCNV integrate additional 
information in CNV prediction (i.e. population allele frequency and distance between adjacent 
SNPs) when compared to QuantiSNP. 
 
CNVs: quality controls 
In spite of the advancement in CNVs detection using genome-wide SNP arrays and better CNV 
prediction algorithms, the concordance of CNVs called by different algorithms is still low (<50%) 
(46).  This implies a high false positive rate in CNV predictions.  To obtain high-confidence calls, 
we only used the overlapping region of CNVs called by PennCNV and QuantiSNP.  Before 
selecting the overlapping CNV regions, quality controls were done separately for the CNV 
predicted by two programs.   
For both PennCNV and QuantiSNP callings, CNVs shorter than 1kb or called with fewer 
than 3 probes were removed.  In addition to these filtering criteria, we also remove CNVs with 
maximum Bayes factor less than 10 for the predictions by QuantiSNP.  In the analysis, only 
those regions intersected by CNVs called by both programs were included.  Samples with 
genome-wide LRR standard deviation greater than 3.5 or with more than 500 CNVs called were 
excluded from the analysis (patients=5; controls=17).    
 CNVs might be artificially split by either of the calling programs.  To circumvent this 
issue, adjacent CNVs of the same type (i.e. duplication or deletion) were merged if the length of 
gap in between was shorter than half of total length of the two consecutive CNV segments.   
 After quality control, 170 ARM cases (Northern Chinese: 98, Southern Chinese: 72) and 
851 controls (Northern Chinese: 37, Southern Chinese: 784) with 4,129 and 21,027 CNVs 
respectively in total were analyzed for the discovery of disease-associated CNV regions.  
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CNVs Analysis  
Common copy number polymorphisms (CNPs) analysis, CNV replication and CNV validation 
are detailed in the supplementary material.  
 
Rare CNVs 
Rare CNVs are defined as CNVs that are observed in less than 1% of samples in the dataset (i.e. 
observed in less than or equal to 10 samples in this study).  We firstly compared the global 
burden of rare CNVs between cases and controls.  Then, we defined rare copy number variation 
regions (rare CNVRs; supplementary material) and analyzed each of them individually.   
 
Global burden 
Global burden tests were performed in terms of CNV length, number of CNVs and genes 
overlapped.  Permutations tests conducted by PLINK were used to determine the statistical 
significance (1,000,000 permutations for each burden test).  The global burden tests were used to 
examine the possible differences in terms of common or rare CNVs enrichment between (i) 
ARM-patients and controls (empirical 1-sided p-values are reported); and (ii) Northern Chinese 
controls and Southern Chinese controls (empirical 2-sided p-values are reported).  The 
enrichment of long CNVs (defined as those CNVs with length longer than 1Mb) between ARM-
patients and controls was also examined (empirical 1-sided p-values are reported). 
 
Gene-based CNV analysis 
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With the overlapped CNV calls from pennCNV and quantiSNP, we selected those gene regions 
that were only found to be disrupted in the ARMs cases, but not in the 868 controls or the 11,943 
unique normal individuals from the Database of Genomic Variants (DGV).  We then examined 
the developmental genes that were only disrupted in ARMs cases.  
 
Mouse anorectum organotypic culture 
Timed pregnant mice (strain ICR) at embryonic day E12 were sacrificed.  The embryonic 
anorectums were treated and cultured as described previously (47).  Different treatments were 
applied to simulate different conditions: (i) as control: control culture was treated with PBS 
containing 0.1%BSA; (ii) excess of Dkk4 protein (secreted protein): recombinant mouse Dkk4 
(R&D) proteins were added to the culture medium at a concentration of 1.5µg/ml.  
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LEGENDS TO FIGURES 
 
Figure 1: UCSC Genome Browser showing the two ARMs implicated genes: (a) DKK4 and 
(b) INTU, and the CNVs interfering with the gene regions. 
(a) UCSC Genome Browser showing the gene region of DKK4 and the part of the 1.32Mb-
duplication (chromosome 8p12-q11.21, 3 copies) observed in an isolated ARM patient 
(MG-IA147C).  The duplication is represented by the blue bar. There is no CNV 
observed in the normal samples submitted to the Database of Genomic Variants (DGV). 
 
(b) UCSC Genome Browser showing the gene region of INTU and the 34kb hemizygous-
deletions in 4q28.1 observed in two ARM patients (MG-IA349C with isolated-ARM; 
MG-IA78C with Down syndrome).  The deletions are represented by the red bars. There 
is no CNV observed in the normal samples submitted to the Database of Genomic 
Variants (DGV). 
 
Figure 2: Validation of CNVs interfering with ARMs implicated genes: (a) DKK4 and (b) 
INTU 
(a) Validation of the duplication (3 copies) spanning the whole DKK4 gene in 1 ARMs case 
(MG-IA147C) and of the normal copy number (2 copies) in other GWAS ARMs cases.  
MG-IA147C (the sixth bar from the left) has 3 DKK4 copies while the rest of samples 
tested had 2 copies.   
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(b) Validation of the deletion (1 copy) spanning INTU in 2 ARMs cases (MG-IA78C and 
MG-IA349C) and of the normal copy number (2 copies) in other GWAS ARMs cases.  
MG-IA78C and MG-IA349C (the two rightmost bars) have 1 copy while other GWAS 
subjects had 2 copies.   
(c) Validation of the duplication (3 copies) spanning the whole DKK4 gene in 1 ARMs case 
(MG-IA147C) and proofing it to be a de novo event by validating the normal copy 
number in the parents (MG-IA147A and MG-IA147B) of this ARMs case.
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Figure 3:  Excess of Dkk4 protein led to ARMs as shown by mouse embryonic anorectum 
culture.  Mid-sagittal sections of the anorectums of E12 (a) and E13.5 (b) ICR mouse embryos 
were shown. Organ culture of E12 anorectums from ICR mice treated for 36 hours in culture 
with (c) 1% BSA as control (Ctrl), and (d) 1.5 mg/ml of Dkk4 protein (+DKK4) were processed 
and sectioned.  Mid-sagittal sections of cultured anorectums were shown. In control culture, the 
genital tubercle has grown distally after 36 hours. The urorectal septum has elongated and 
reached the cloaca membrane (c).  In contrast, treatment with Dkk4 protein (d) perturbed the 
growth of the urorectal septum and resulted in the lack of cloaca compartmentalisation. The 
hollow space resembled the phenotype of persistent cloaca as shown in the mid-sagittal section 
depicted in Figure 3b.  However, the distal growth of the genital tubercle appeared unaffected by 
the addition of Dkk4 protein. 
Abbreviations: cl, cloaca; cm, cloaca membrane; hg, hindgut; GT, genital tubercle; ugs, 
urogenital sinus; urs, urorectal septum.  Bar 0.05mm.  Dotted lines demarcate the hindgut. 
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TABLES 
Table 1: Global burden of RARE CNVs in ARMs cases and controls 
  
Rare CNVs with length <100kb 
 
Rare CNVs with length >100kb 
    
Cases 
(n=170) 
Controls 
(n=851) 
Empirical  
p-values 
  
Cases 
(n=170) 
Controls 
(n=851) 
Empirical  
p-values 
Total number of segments                 
 
Deletion 538 2165 
  
66 216 
 
  Duplication 218 888 
  
126 374 
 
Number of rare CNVs per sample 
        
 
Deletion 3.165 2.544 0.03945 
 
0.3882 0.2538 0.021955 
  Duplication 1.282 1.043 0.007344 
 
0.7412 0.4395 0.002307 
Proportion of samples with one or more rare CNVs 
        
 
Deletion 0.9059 0.8261 0.00484 
 
0.2647 0.2162 0.100801 
  Duplication 0.6941 0.6381 0.093875 
 
0.4294 0.3467 0.025701 
Total length of rare CNVs spanned per sample (in kb) 
        
 
Deletion 92.21 84.2 0.2479 
 
314.6 268 0.234714 
  Duplication 69.67 57.38 0.01022 
 
505.2 373.9 0.060274 
Number of genic regions spanned by rare CNVs per sample 
        
 
Deletion 1.247 1.905 0.9369 
 
0.4882 0.3384 0.15943 
  Duplication 0.8588 0.6616 0.026837 
 
1.176 0.8461 0.063724 
Number of genic CNVs per sample 
        
 
Deletion 0.5941 0.5347 0.09023 
 
0.1118 0.1234 0.704262 
  Duplication 0.4529 0.3643 0.018863 
 
0.3118 0.2526 0.068167 
Statistical significance was inferred using permutation with 1,000,000 iterations.  Rare CNVs are defined as CNVs that are observed in less than 1% samples of the 
dataset.  ARM cases (isolated: N=126; syndromic: N=44) are enriched with rare deletions and rare duplications by 1.3 fold each.  Separate global burden tests were 
also performed by stratifying the isolated and syndromic ARM patients. Details are presented in the supplementary Table 7. 
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Table 2: Chromosomal aberrations that were only observed in ARM-patients 
Chr Chromosomal aberrations Patient ID  
Isolated (I) or 
Syndromic (S) 
Genes uniquely disrupted 
in cases 
Patients with related symptoms listed in DECIPHER  
(patient record, type of CNV, phenotype) 
1 1.3Mb Duplication in 1q21.1 MG-IA201C I ACP6 record 983: DUP, absent uterus, fused labia, vaginal atresia 
1 2.3Mb Deletion in 1q42.3-q43 MG-IA195C I RBM34, MTR  
1 8.1Mb Deletion in 1q43-q44 MG-IA87C I FAM152A record 249405 
b
: DUP and DEL, megacolon/Hirschsprung 
syndrome, general abnormalities in heart 
2 1.5Mb Deletion in 2q37.3 MG-IA33C I   
5 3.7Mb Deletion in 5p15.33 MG-IA41C I ISL1 record 4119 
b
: DUP, megacolon/Hirschsprung syndrome, 
general abnormalities in heart 
5 1.1Mb Duplication in 5q11.2 MG-IA147C I
a
  record 1946: DEL, intestinal malrotation 
7 1.4Mb Duplication in 7p21.3-p21.2 MG-IA370C I   
7 6.7Mb Duplication in 7p11.1-7p11.21 MG-IA360C I   
8 13.2Mb Duplication in 8p12-q11.21 MG-IA147C I
a
 ZNF703, ERLIN2, PROSC, 
BRF2, RAB11FIP1, 
GOT1L1, ADRB3, ASH2L, 
STAR, DDHD2, 
PPAPDC1B, FGFR1, 
TACC1, C8orf4, GOLGA7, 
GINS4, AGPAT6, NKX6-3, 
AP3M2, DKK4, C8orf40, 
CHRNA6, THAP1, 
CEBPD, SNAI2 
 
11 8.4Mb Duplication in 11q14.3-11q22.1 MG-IA152C I JOSD3, C11orf54, 
MED17, LOC390243, 
GPR83, PIWIL4, 
AMOTL1, CWC15, 
JMJD2D, SFRS2B, 
ENDOD1, FAM76B, 
MTMR2, CCDC82, JRKL 
 
15 1.6Mb Duplication in 15q13.2-q13.3 MG-IA230C I   
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22 2.6Mb Deletion in 22q11.21 MG-IA162C I SERPIND1, SNAP29 record 252033
 b
: DUP, anal atresia/stenosis, general 
abnormalities in sacrum and kidneys;  
record 2366 
b
: DEL, anal atresia/stenosis, general heart 
abnormalities;  
record 249397 
 b
: DEL, megacolon/ Hirschsprung;  
record 622
 b
: DEL, absent uterus, general abnormalities in 
kidneys;  
record 1645
 b
: DEL, malformed uterus, renal agenesis, fusion 
of vertebrae 
Chromosomal aberrations are defined as CNVs with length longer than 1Mb. The patient IDs are listed to show the number of patients harboring the 
chromosomal aberrations. The chromosomal aberrations were also checked against the DECIPHER database for any other patients with similar or ARM-
related symptoms. a patient was diagnosed with autisms at the age of 6; b this is the only chromosomal aberration observed in this DECIPHER patient  
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Table 3: Results of the top three rare CNV regions from the permutation test and Fisher’s exact test.  
Chr. 
Starting 
position 
(in hg18) 
Ending 
position 
(in hg18) 
Number 
of cases 
Number of 
controls 
Permutation test  Fisher’s exact test 
Empirical 
p-values  
Empirical p-
values corrected 
for all tests 
 p-values  
p-values after 
Bonferroni 
correction 
7 38285115 38330273 7 0 2.00 x10
-06
 0.000147  3.20x10
-06
 0.00779436 
14 21937715 22009307 6 0 0.000134 0.001372  1.98 x10
-05
 0.048239486 
1 40794563 40804646 7 3 0.000240 0.022894  0.000243573 0.594073571 
Genic and non-genic regions are defined as those that harbour at least one CNV in cases or controls.  These three regions do 
not harbor any genes, i.e. non-genic regions.  P rmutation tests (1,000,000 iterations) were performed on 2439 rare CNV 
regions (1982 genic regions and 457 non-genic regions) by using PLINK.  According to PLINK, the empirical p-values 
corrected for all the tests were calculated by comparing each observed test statistic against the maximum of all permuted 
statistics (i.e. over all regions) for each single replicate.  We also performed the Fisher’s exact test on these regions, and 
included a Bonferroni correction for 2439 total CNV regions. 
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Abbreviations 
Anorectal Malformation              ARM 
Copy Number Polymorphism             CNP 
Copy Number Variation Region            CNVR 
Copy Number Variation             CNV 
Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources    DECIPHER 
Database of Genomic Variants            DGV 
Dickkopf homolog 4 (Xenopus laevis)           DKK4 
The European Cytogeneticists Association Register of Unbalanced Chromosome Aberrations    ECARUCA 
Inturned planar cell polarity effector homolog          INTU 
Planar Cell Polarity              PCP 
Principal Components Analysis            PCA 
Quality Control              QC 
Single Nucleotide Polymorphism            SNP 
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